* Vyant Bio Inc VYNT.OQ VYNT.O is expected to report
results on May 16.
* The Cherry Hill New Jersey-based company is expected to
report
revenue of $300 thousand, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Vyant Bio Inc is
for a
loss of 16 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Vyant Bio
Inc is
$4, above its last closing price of $0.66.
This summary was machine generated May 14 at 00:30 GMT. All
figures in US dollars unless otherwise stated